Detalles de la búsqueda
1.
Comprehensive genomic evaluation of advanced and recurrent breast cancer patients for tailored precision treatments.
BMC Cancer
; 24(1): 85, 2024 Jan 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-38229073
2.
Multicenter, single-arm, phase II study of the continuous use of panitumumab in combination with FOLFIRI after FOLFOX for RAS wild-type metastatic colorectal cancer: Exploratory sequential examination of acquired mutations in circulating cell-free DNA.
Int J Cancer
; 151(12): 2172-2181, 2022 Dec 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-35723084
3.
Efficacy of celecoxib as preemptive analgesia for patients undergoing laparoscopic inguinal hernia repair: a randomized trial.
Surg Today
; 51(7): 1118-1125, 2021 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-33389189
4.
Phase Ib/II Study of Biweekly TAS-102 in Combination with Bevacizumab for Patients with Metastatic Colorectal Cancer Refractory to Standard Therapies (BiTS Study).
Oncologist
; 25(12): e1855-e1863, 2020 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-32666647
5.
Phase II study of 5-fluorouracil-leucovorin plus bevacizumab for chemotherapy-naïve older or frail patients with metastatic colorectal cancer (OGSG 0802).
Int J Clin Oncol
; 25(7): 1291-1298, 2020 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-32219630
6.
[A Study on the Status of End-of-Life Chemotherapy for Solid Cancer after the Introduction of New Anti-Cancer Drugs].
Gan To Kagaku Ryoho
; 47(13): 2236-2238, 2020 Dec.
Artículo
en Japonés
| MEDLINE | ID: mdl-33468919
7.
Phase III randomised trial comparing 6 vs. 12-month of capecitabine as adjuvant chemotherapy for patients with stage III colon cancer: final results of the JFMC37-0801 study.
Br J Cancer
; 120(7): 689-696, 2019 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-30833647
8.
Biweekly S-1 plus oxaliplatin (SOX) reintroduction in previously treated metastatic colorectal cancer patients (ORION 2 study): a phase II study to evaluate the efficacy and safety.
Int J Clin Oncol
; 24(7): 836-841, 2019 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-30778794
9.
[A Case of an Elderly Patient with Multiple Lung Metastases of Postoperative Pancreatic Cancer in Whom Lung Metastases Were Controlled by Biweekly Dose-Down Administration of Gemcitabine].
Gan To Kagaku Ryoho
; 46(9): 1453-1455, 2019 Sep.
Artículo
en Japonés
| MEDLINE | ID: mdl-31530789
10.
Surgical outcome of laparoscopic hepatic resection for hepatocellular carcinoma: A matched case-control study with propensity score matching.
J Minim Access Surg
; 14(4): 277-284, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-29226881
11.
Phase II study of S-1 plus leucovorin in patients with metastatic colorectal cancer: Regimen of 1 week on, 1 week off.
Cancer Sci
; 108(10): 2045-2051, 2017 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-28763145
12.
Preplanned safety analysis of the JFMC37-0801 trial: a randomized phase III study of six months versus twelve months of capecitabine as adjuvant chemotherapy for stage III colon cancer.
Int J Clin Oncol
; 22(3): 494-504, 2017 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-28078540
13.
Multicenter randomized phase II clinical trial of oxaliplatin reintroduction as a third- or later-line therapy for metastatic colorectal cancer-biweekly versus standard triweekly XELOX (The ORION Study).
Int J Clin Oncol
; 21(3): 566-72, 2016 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-26475356
14.
Level of arterial ligation in sigmoid colon and rectal cancer surgery.
World J Surg Oncol
; 14: 99, 2016 Apr 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-27036117
15.
The rare BRAF VK600-601E mutation as a possible indicator of poor prognosis in rectal carcinoma a report of a case.
BMC Med Genet
; 16: 1, 2015 Jan 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-25636897
16.
Multicenter Phase II study of FOLFOX or biweekly XELOX and Erbitux (cetuximab) as first-line therapy in patients with wild-type KRAS/BRAF metastatic colorectal cancer: The FLEET study.
BMC Cancer
; 15: 695, 2015 Oct 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-26467662
17.
Capecitabine and oxaliplatin combined with bevacizumab are feasible for treating selected Japanese patients at least 75 years of age with metastatic colorectal cancer.
BMC Cancer
; 15: 786, 2015 Oct 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-26497654
18.
The SOFT trial: a Phase III study of the dihydropyrimidine dehydrogenase inhibitory fluoropyrimidine S-1 and oxaliplatin (SOX) plus bevacizumab as first-line chemotherapy for metastatic colorectal cancer.
Future Oncol
; 11(10): 1471-8, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-25963425
19.
[A Case of Gastric Cancer Associated with Sjögren's Syndrome and Interstitial Pneumonia].
Gan To Kagaku Ryoho
; 42(12): 1974-6, 2015 Nov.
Artículo
en Japonés
| MEDLINE | ID: mdl-26805235
20.
[A Case of Bullous Pemphigoid Relieved after Sigmoid Colon Cancer Resection].
Gan To Kagaku Ryoho
; 42(12): 2128-9, 2015 Nov.
Artículo
en Japonés
| MEDLINE | ID: mdl-26805286